Belongs to

• Gynecology Disease Management Team

Types of Work

["2022"]

[[["Journal Articles",916],["Meeting Abstracts",825],["Reviews",46],["Book Sections",38],["Editorials",28],["Guidelines",18],["Correspondences",7],["Research Letters",1]]]

[1879]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• middle aged
• ovarian cancer

Recent Works

1. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: Overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

   Journal Article

   Eskander, R. N.; Sill, M. W.; Beffa, L.; Moore, R. G.; Hope, J. M.; Musa, F. B.; Mannel, R. S.; Shahin, M. S.; Cantuaria, G. H.; Girda, E.; more...
   Nature Medicine (2025)

   Fulltext@MSK | Save
2. Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

   Journal Article

   Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
   The Oncologist (2025)

   Fulltext@MSK | Save
3. Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis

   Journal Article

   Lam, C.; Zhou, Q.; Aghajanian, C.; Abu-Rustum, N. R.; Mueller, J. J.; Ellenson, L. H.; Green, A. K.; Weigelt, B.; Jungbluth, A. A.; Momeni-Boroujeni, A.
   Gynecologic Oncology (2025)

   Fulltext@MSK | Save